Results 81 to 90 of about 3,933 (119)

HPV Infection and Oxidative Stress in Cervical Carcinogenesis: Linking Apoptosis, Senescence, SASP, and EMT. [PDF]

Antioxidants (Basel)
Despot A, Fureš R, Despot AM, Hrgović Z, Gredičak M, Malinac Malojčić S, Ćosić V, Mešić L, Sinković N, Sabol I.   +9 more
europepmc   +1 more source

The SMAC-mimetic xevinapant differentially enhances cisplatin and immune checkpoint blockade efficacy in high-risk HPV-positive tumors. [PDF]

Transl Oncol
Tsai TY, Kawabe M, Kaga AN, Okamoto K, Myers JN, Osman AA.   +5 more
europepmc   +1 more source

The Role of HPV and Hormone in Cervical Precancer and Cancer: Molecular Pathophysiology and Cell Biology of Disease and Treatment. [PDF]

Oncol Res
Kao PY, Chen JH, Chen KH.
europepmc   +1 more source

In Vitro Model Characterizing Carcinogenic Progression of HPV-Positive Oropharyngeal Cancer. [PDF]

Cancers (Basel)
Avila Tejeda J, Chatterjee S, Meyers C.
europepmc   +1 more source

Molecular heterogeneity of HPV-associated cancers and strategies to overcome treatment resistance. [PDF]

Cancer Heterog Plast
Rasouli S, Gong W, Wood R, Daneshdoust D, Khan A, Mahyoob R, Cao C, Yu Z, Putluri N, Shvets G, Li H, Zhao B, Liu X, Li J.   +13 more
europepmc   +1 more source

Buschke-Löwenstein Tumor of the Vulva: Clinical Neglect, Molecular Continuum, and Pathogenetic Insights. [PDF]

Cureus
Martínez-Ortega JI, Rosas-Lezama FI, Ramirez Cibrian AG.   +2 more
europepmc   +1 more source

Preventive and therapeutic efficacy of mRNA/LNP vaccines encoding HPV16 E6 and E7 in an early-intervention HPV tumor mouse models. [PDF]

Hum Vaccin Immunother
Saithong S, Prompetchara E, Ketloy C, Khawsang C, Tharakhet K, Kaewpang P, Yostrerat N, Wangsoontorn P, Charsangbong K, Lam K, Heyes J, Weissman D, Ruxrungtham K.   +12 more
europepmc   +1 more source

Emerging Therapeutic Strategies for HPV-Related Cancers: From Gene Editing to Precision Oncology. [PDF]

Curr Issues Mol Biol
Cakir MO, Kayhan G, Yilmaz B, Ozdogan M, Ashrafi GH.   +4 more
europepmc   +1 more source

Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations. [PDF]

Front Cell Infect Microbiol
Liu W, Jiang Y, Wang C, Wang M, Zhang W, Ren H, Xu S, Qin J, Liu P, Jin L, Zhao D.   +10 more
europepmc   +1 more source

The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus Associated Cervical Cancer. [PDF]

Curr Issues Mol Biol
Vidalina D, Ghali L, Kassouf N, Li S, Li D, Wen X.   +5 more
europepmc   +1 more source